Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 4/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | GLP1R | P43220 | 8/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12964752 | 0.92 | ALB (0.48) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL17040363 | 0.88 | ALB (0.52) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL29322234 | 0.87 | GLP1R (0.52) | ALBFOLH1GLP1RNOD1EPHX2 | |
| SCHEMBL20122043 | 0.86 | ALB (0.58) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL18375484 | 0.85 | ALB (0.56) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL12964947 | 0.84 | ALB (0.55) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL15451405 | 0.81 | NOD1 (0.62) | ALBFOLH1GLP1RNOD1 | |
| SCHEMBL17359223 | 0.81 | ALB (0.52) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL14685805 | 0.81 | ALB (0.52) | ALBFOLH1GLP1RNOD1SMN1; SMN2 | |
| SCHEMBL13214020 | 0.80 | ALB (0.51) | ALBFOLH1GLP1RNOD1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015124612-A1 | STABLE GLUCAGON ANALOGUES AND USE FOR TREATMENT OF HYPOGLYCAEMIA | NOVO NORDISK A/S (DK) | 2015-08-27 | — | — | WO | disclosed |